Composition and kit for detecting and typing multiple intestinal pathogens and application of composition and kit
Through the multi-fluorescence PCR analysis method, upstream and downstream primers and probes for detecting multiple enteric pathogens are solved, and the problem of difficulty in rapid and accurate detection and classification in the prior art is achieved, and high sensitivity and specificity are achieved for these pathogens. Testing and support timely preventive measures for public health.
Patent Information
- Application Number
- CN202411127189.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-15
- Publication Date
- 2024-12-03
AI Technical Summary
The prior art is difficult to detect and type a variety of enteric pathogens quickly and accurately, such as Campylobacter jejuni, Campylobacter colon, Vibrio, Aeromonas hydrophila and Cronobacter sakazaki, which leads to difficulties in public health problems. Effective prevention.
Multiple fluorescence PCR analysis method is used to detect different sites, and provide upstream and downstream primers and probes for detecting these pathogens, so as to simultaneously detect and distinguish these pathogens in a single-tube reaction system, improving the sensitivity and specificity of the detection.
It has achieved rapid and accurate detection and typing of a variety of intestinal pathogens, provided targeted treatment strategies, and the sensitivity reaches 200 copies/mL, enhancing the timeliness and effectiveness of prevention policies.
Smart Images

Figure CN119061171A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of molecular biological detection, and in particular, relates to a composition and use for detecting and typing a variety of intestinal pathogens, such as Campylobacter jejuni, Campylobacter coli, Vibrio fluvii, Aeromonas hydrophila, and Cronobacter sakazakii. Background Art
[0002] Campylobacter is one of the four major global causes of diarrheal disease. Foodborne diseases can have serious consequences. Diarrhea is the most common disease caused by unsafe food. The high incidence of Campylobacter diarrhea, coupled with its course and possible complications, makes the disease of high socioeconomic importance. Campylobacter is mainly spiral, S-shaped or arc-shaped, and rod-shaped bacteria. Currently, there are 17 species and 6 subspecies of bacteria classified as Campylobacter, of which Campylobacter jejuni and Campylobacter coli are the most frequently reported in human diseases. It is of great significance to accurately type and identify the common Campylobacter species of Campylobacter.
[0003] Vibrio fluvialis is a halophilic, Gram-negative, facultative anaerobic bacterium widely distributed in seawater and slightly saline harbor and river water. It can cause Vibrio fluvialis enteritis in humans. The clinical symptoms are very similar to cholera-like diarrhea, causing sporadic and epidemic diarrhea worldwide. It is the second most pathogenic Vibrio in the genus Vibrio after Vibrio cholerae and Vibrio parahaemolyticus. Infection caused by Vibrio fluvialis is a public health issue that cannot be ignored.
[0004] Clostridium sakazakii belongs to the genus Clonobacter of the family Enterobacteriaceae. It is a Gram-negative, facultative anaerobic, rod-shaped bacterium. Most species of Clonobacter are pathogens of adults and cause opportunistic infections in immunocompromised hosts. Although it occasionally infects young children, the mortality rate after infection is high (40–80%). In infants, it can cause bacteremia, meningitis, and necrotizing enterocolitis.
[0005] Aeromonas hydrophila belongs to the Vibrio family, is Gram-negative, has a single flagellum and is motile, has no capsule, and does not form spores. The main virulence factors of this bacterium are enterotoxins, including cholera-like toxin (CT) and Escherichia coli-like heat-resistant toxin (LT). Cold-blooded animals such as fish and frogs are the natural hosts of this bacterium and are the main source of human infection. Patients with the bacteria can also cause human-to-human transmission. Infection can be caused by drinking beverages or food contaminated by this bacterium, or skin wounds come into contact with water contaminated by this bacterium, or by fish thorns or bites. Drinking unsterilized water in summer may cause an outbreak of Aeromonas hydrophila gastroenteritis. People with low immune function, such as intestinal carriers, are prone to endogenous blood, abdominal, bile duct, wound or urethral infections.
[0006] Therefore, there is a need in the art for a product that can simply and quickly detect the above-mentioned pathogens with high sensitivity and good specificity, which is conducive to the timely provision of prevention policies. Summary of the invention
[0007] In view of this, in a first aspect, the present invention provides a composition for detecting and typing multiple intestinal pathogens, comprising upstream and downstream primers and probes for detecting at least 4 of the following multiple intestinal pathogens:
[0008] Upstream and downstream primers and probes for detecting Campylobacter jejuni as shown in SEQ ID NOs: 1 to 3;
[0009] A probe for detecting Campylobacter coli and upstream and downstream primers as shown in SEQ ID NOs: 4 to 6;
[0010] Upstream and downstream primers and probes for detecting Vibrio fluvibrios as shown in SEQ ID NOs: 7 to 9;
[0011] Upstream and downstream primers and probes for detecting Aeromonas hydrophila as shown in SEQ ID NOs: 10 to 12; or
[0012] The upstream and downstream primers and probes for detecting Cronobacter sakazakii are shown in SEQ ID NOs: 13 to 15.
[0013] The combined detection composition provided by the present invention mainly uses a multiplex fluorescent PCR analysis method to detect and type a variety of intestinal pathogens by detecting different sites, thereby simultaneously realizing the detection and differentiation of at least four pathogens of Campylobacter jejuni, Campylobacter coli, Vibrio fluvii, Aeromonas hydrophila, and Cronobacter sakazakii in a single-tube reaction system, so as to provide a targeted strategy for subsequent treatment. At the same time, the composition of the present invention has a higher detection sensitivity of 200 copies / mL, and the detection is more accurate, which is conducive to the timely provision of prevention policies.
[0014] Furthermore, the present invention provides a composition for detecting and typing a plurality of intestinal pathogens, comprising:
[0015] Upstream and downstream primers and probes for detecting Campylobacter jejuni as shown in SEQ ID NOs: 1 to 3;
[0016] A probe for detecting Campylobacter coli and upstream and downstream primers as shown in SEQ ID NOs: 4 to 6;
[0017] Upstream and downstream primers and probes for detecting Vibrio fluvibrios as shown in SEQ ID NOs: 7 to 9;
[0018] Upstream and downstream primers and probes for detecting Aeromonas hydrophila as shown in SEQ ID NOs: 10 to 12; and
[0019] The upstream and downstream primers and probes for detecting Cronobacter sakazakii are shown in SEQ ID NOs: 13 to 15.
[0020] Furthermore, the composition includes upstream and downstream primers and probes for detecting the internal standard.
[0021] In some specific embodiments, the internal standard is a human internal standard gene. In a specific embodiment, the internal standard is a human housekeeping gene.
[0022] Furthermore, the fluorescent groups of the probes in the composition of the present invention are different from each other and do not interfere with each other.
[0023] In this article, "different from each other and not interfering with each other" means that the fluorescent groups used in each probe in the composition are different and will not affect each other's detection, that is, different channels can be used for detection. For example, ATTO425, Quasar705, FAM, HEX, ROX, CY5 and CY5.5 can be used. The absorbance values of these groups are not close, and different channels can be selected, so they will not interfere with each other.
[0024] Further, in some embodiments, the composition of the present invention may include one or more pairs of the above primer and probe pairs. In the present invention, "pair" refers to an upstream primer, a downstream primer and a probe that match each other to detect a target.
[0025] The composition of the present invention can be combined into any combination of detection corresponding to 5 targets. Those skilled in the art can combine as needed to detect which targets, that is, to combine the primers and probe pairs corresponding to the targets. These combinations are all included in the present invention.
[0026] For example, it may include any 4 pairs of the above 5 pairs of primers and probes, it may include any 3 pairs of the above 5 pairs of primers and probes, it may include any 2 pairs of the above 5 pairs of primers and probes, or it may include any 1 pair of the above 5 pairs of primers and probes.
[0027] In some specific embodiments, the compositions of the present invention are used for fluorescent PCR.
[0028] In a specific embodiment, the fluorescent reporter group of the Campylobacter jejuni probe is FAM; the fluorescent reporter group of the Campylobacter coli probe is HEX; the fluorescent reporter group of the Vibrio fluvial probe is ROX; the fluorescent reporter group of the Aeromonas hydrophila probe is CY5; and the fluorescent reporter group of the Cronobacter sakazakii probe is Quasar 705.
[0029] Furthermore, the 3' end of the probe also has a non-fluorescent quencher.
[0030] Furthermore, the 3' end of the probe also has a quencher group, such as MGB, BHQ1 or BHQ2.
[0031] In a specific embodiment, the 3' end of the probe is MGB.
[0032] Furthermore, the amount of the primer in the composition is 0.1-0.5 μM; the amount of the probe in the composition is 0.1-0.3 μM.
[0033] In a specific embodiment, each component of the composition of the present invention is present in a separate package.
[0034] In a particular embodiment, the components of the composition of the present invention are present in the same package.
[0035] Furthermore, the components of the composition of the present invention are present in a mixed form.
[0036] In a second aspect, the present invention provides the use of the above-mentioned composition of the present invention in the preparation of a kit for detecting, typing and distinguishing multiple intestinal pathogens, wherein the types of the multiple intestinal pathogens are at least 4 of Campylobacter jejuni, Campylobacter coli, Vibrio fluvialis, Aeromonas hydrophila, and Cronobacter sakazakii.
[0037] In a third aspect, the present invention provides a kit for detecting, typing and distinguishing a variety of intestinal pathogens, wherein the kit comprises the composition of the present invention as described above.
[0038] Furthermore, the kit also includes a negative quality control product and a positive quality control product.
[0039] In a specific embodiment, the negative control is at least one of DEPC H2O, physiological saline, and internal standard gene. The positive control is at least one of the plasmid or fragment gene of Campylobacter jejuni, Campylobacter coli, Vibrio fluvii, Aeromonas hydrophila, and Cronobacter sakazakii.
[0040] Furthermore, the kit also includes a nucleic acid amplification reagent.
[0041] Furthermore, the amplification reagent includes dNTP, PCR buffer, DNA polymerase, and Mg 2+ At least one of .
[0042] Furthermore, the kit also includes: a nucleic acid releasing reagent and a nucleic acid extracting reagent.
[0043] Furthermore, the concentration of the DNA polymerase is 3U / reaction to 50U / reaction, for example, the DNA polymerase may be Taq enzyme.
[0044] In a specific embodiment, the kit of the present invention comprises: Taq enzyme, Mg 2+ , Mn 2+ , dNTPs, primers, probes and PCR buffer.
[0045] Common PCR buffers are composed of Tris-HCl, MgCl2, KCl, Triton X-100, etc. The total volume in a single PCR reaction tube is generally 20 μl to 200 μl.
[0046] In a fourth aspect, a method for detecting and typing multiple intestinal pathogens is provided, the method comprising the following steps:
[0047] 1) Extracting nucleic acid from the sample to be tested;
[0048] 2) using the composition of the present invention or the kit of the present invention as described above to perform fluorescent quantitative PCR on the nucleic acid obtained in step 1);
[0049] 3) Obtain and analyze the results.
[0050] In the present invention, the sample used for detection may be feces, intestinal secretions, etc., but is not limited thereto.
[0051] Furthermore, the reaction conditions of the fluorescent quantitative PCR are:
[0052] UNG enzyme reaction, temperature is 50-60°C, time is 1-4 minutes, 1 cycle; Taq enzyme activation, temperature is 90-99°C, time is 5-600 seconds, 1 cycle; denaturation, temperature is 95°C, time is 5-20 seconds, annealing, temperature is 55°C-60°C, time is 10-60 seconds, 30-50 cycles, and fluorescence is collected.
[0053] In a specific embodiment, a method for detecting and typing a plurality of intestinal pathogens for non-diagnostic purposes is provided, the method comprising the following steps:
[0054] 1) Extracting nucleic acid from the sample to be tested;
[0055] 2) using the composition of the present invention or the kit of the present invention as described above to perform fluorescent quantitative PCR on the nucleic acid obtained in step 1);
[0056] 3) Obtain and analyze the results.
[0057] Furthermore, the reaction conditions of the fluorescent quantitative PCR are:
[0058] UNG enzyme reaction, temperature is 50-60°C, time is 1-4 minutes, 1 cycle; Taq enzyme activation, temperature is 90-99°C, time is 5-600 seconds, 1 cycle; denaturation, temperature is 95°C, time is 5-20 seconds, annealing, temperature is 55°C-60°C, time is 10-60 seconds, 30-50 cycles, and fluorescence is collected.
[0059] In a specific embodiment, a composition is provided for preparing a composition for detecting and typing a plurality of intestinal pathogens, wherein the use detection comprises the following steps:
[0060] 1) Extracting nucleic acid from the sample to be tested;
[0061] 2) using the composition of the present invention or the kit of the present invention as described above to perform fluorescent quantitative PCR on the nucleic acid obtained in step 1);
[0062] 3) Obtain and analyze the results.
[0063] Furthermore, the reaction conditions of the fluorescent quantitative PCR are:
[0064] UNG enzyme reaction, temperature is 50-60°C, time is 1-4 minutes, 1 cycle; Taq enzyme activation, temperature is 90-99°C, time is 5-600 seconds, 1 cycle; denaturation, temperature is 95°C, time is 5-20 seconds, annealing, temperature is 55°C-60°C, time is 10-60 seconds, 30-50 cycles, and fluorescence is collected. BRIEF DESCRIPTION OF THE DRAWINGS
[0065] Figures 1 to 3 A graph showing the test results of different sample combinations of the composition of the present invention;
[0066] Figure 4 It is the sensitivity result diagram of the composition of the present invention;
[0067] Figure 5 It is a specific result diagram of the composition of the present invention;
[0068] Figure 6 It is a test result diagram of the comparative example composition of the present invention. DETAILED DESCRIPTION
[0069] The present invention will be described in detail below in conjunction with specific embodiments and examples, and the advantages and various effects of the present invention will be more clearly presented. It should be understood by those skilled in the art that these specific embodiments and examples are used to illustrate the present invention, rather than to limit the present invention.
[0070] Example 1: Primers and probes used in the present invention
[0071] Table 1
[0072]
[0073] The fluorescent reporter group of the Campylobacter jejuni probe is FAM; the fluorescent reporter group of the Campylobacter coli probe is HEX; the fluorescent reporter group of the Vibrio fluvial probe is ROX; the fluorescent reporter group of the Aeromonas hydrophila probe is CY5; and the fluorescent reporter group of the Cronobacter sakazakii probe is Quasar 705.
[0074] Example 2: Method for detecting and typing multiple intestinal pathogens
[0075] The samples detected by the present invention are feces, intestinal secretions, etc. The real-time fluorescence PCR reaction system is configured according to the following Table 2:
[0076] Table 2
[0077] Components Volume / concentration in each reaction PCR Buffer 34.8μL Primer (50pmol / μL) 0.20μL / strip Probe (50pmol / μL) 0.10μL / strip dNTPs(100mM) 0.5μL <![CDATA[Mg 2+ ]]> 0.2μL DEPC water Make up to 38.0 μL
[0078] Preparation of enzyme mixture:
[0079] The enzyme mixture consists of UNG enzyme and H-Taq enzyme. H-Taq enzyme (15U / μL) and UNG enzyme (1U / μL) are mixed in a certain ratio (1.8μL H-Taq enzyme and 0.2μL UNG enzyme per person). The enzyme mixture is used in an amount of 2μL per person.
[0080] Reagent preparation:
[0081] Take the corresponding amount of PCR reaction solution and enzyme mixture (PCR reaction solution 38 μL / person + enzyme mixture 2 μL / person) in proportion, and mix them thoroughly to form a PCR mixture.
[0082] Sample handling and loading:
[0083] Take 300 μL of the sample to be tested, negative control, and positive control into a 1.5 mL centrifuge tube, and use the nucleic acid extraction or purification reagent of Shengxiang Biotechnology Co., Ltd. according to its instructions to extract nucleic acid.
[0084] 10 μL of the above-treated samples, negative controls and positive controls were pipetted and added to reaction tubes respectively. 40 μL of PCR mixture was added to each reaction tube and the tube cap was covered.
[0085] PCR amplification:
[0086] On the fully automatic medical PCR analysis system, PCR amplification is performed according to a certain temperature and time setting program. The PCR amplification program is set as shown in Table 3 below:
[0087] Table 3
[0088]
[0089] If the FAM, HEX, CY5, ROX and Quasar705 channels have obvious S-shaped amplification curves and the Ct value is ≤38, it is judged as positive; if the FAM, HEX, ROX and Quasar705 channels have no amplification curve (No Ct) or the Ct value is greater than 38, and CY5≤38, it is judged as negative; if the FAM, HEX, ROX and Quasar705 channels have no amplification curve (No Ct) or the Ct value is greater than 38, and CY5 is greater than 38, the result is unreliable and needs to be retested; the details are shown in Table 4.
[0090] Table 4. Interpretation of test results
[0091]
[0092] Example 3: Test results of the test samples of the composition of the present invention
[0093] The primers and probes shown in Example 1 were verified according to the method of Example 2 on samples of Campylobacter jejuni, Campylobacter coli, Vibrio fluvii, Aeromonas hydrophila, and Cronobacter sakazakii. The results showed that the composition of the present invention can detect and distinguish any combination of the above-mentioned multiple intestinal pathogens. For example, the composition of the present invention detects:
[0094] Campylobacter jejuni, Campylobacter coli, Vibrio fluvii, Cronobacter sakazakii ( Figure 1 );
[0095] Campylobacter jejuni, Vibrio fluvii, Aeromonas hydrophila, Cronobacter sakazakii ( Figure 2 );
[0096] Campylobacter jejuni, Campylobacter coli, Vibrio fluvii, Aeromonas hydrophila, Cronobacter sakazakii ( Figure 3 ).
[0097] These figures prove that the present invention is a 6-plex PCR that can amplify the above-mentioned 5 targets at one time and can be distinguished using a multi-channel PCR instrument. It also proves that any corresponding pair of combinations of the compositions of the present invention can detect any corresponding combination of pathogens.
[0098] Example 4: Sensitivity of the composition of the present invention
[0099] Using the composition in Example 1 of the present invention, LOD (sensitivity) detection was performed on each target to simulate clinical samples and multiplex PCR detection was performed on a fluorescent quantitative PCR instrument. Figure 4 As shown in Table 5, each channel can still accurately detect samples as low as 200 copies / mL, indicating that the sensitivity of the composition of the present invention is 200 copies / mL.
[0100] Table 5
[0101]
[0102] Example 5. Specificity of the composition of the present invention
[0103] The composition of the present invention has no cross reaction with common pathogens and other pathogens with similar infection symptoms (such as norovirus, rotavirus, enteric adenovirus, Enterococcus faecalis, Enterococcus faecium, Staphylococcus aureus, Salmonella typhi, Salmonella paratyphi, Salmonella enteritidis, Yersinia enterica, Shigella, Escherichia coli O157, Clostridium difficile, Clostridium perfringens, Helicobacter pylori, enterovirus 71, astrovirus, etc.). The results are as follows Figure 5 As shown, it is shown that the composition of the present invention has good specificity.
[0104] Example 6. Anti-interference and stability of the composition of the present invention
[0105] The composition of the embodiment was analyzed for interferences by conventional methods. The experimental results showed that potential PCR inhibitors / interfering substances such as dexamethasone (50 μg / mL), gentamicin (50 μg / mL), vancomycin (50 μg / mL), cefmenoxime hydrochloride (50 μg / mL), ciprofloxacin (50 μg / mL), co-trimoxazole (50 μg / mL), clindamycin (50 μg / mL), heme (10 μg / mL), hemoglobin (10%), etc. at certain concentrations had no obvious effect on the kit. The amplification results of the PCR reaction solution in the presence of infectious substances are specifically shown in Table 6 below.
[0106] Table 6
[0107]
[0108] Comparative Example 1: Other primers and probes designed by the present invention that have poor effects
[0109] Due to the principle of complementary base pairing, dimers will form between primers and (or) probes, but this probability is very small and can be ruled out at the beginning of the design. However, when multiple pathogens are detected together, there are many primers and probes, and dimers are likely to occur between primers and primers, probes and probes, or primers and probes. In order to ensure the conservatism of the design (conservatism is crucial to the accuracy of the detection), and to consider the mutual interference between different primers and probes, the primers and probes need to be carefully designed.
[0110] Therefore, the inventors also designed some other primers and probes to form a different detection system 2 (the sequences are shown in Table 7, with the primers and probe sequences of Aeromonas hydrophila replaced), which is also used to detect the above pathogens. Figure 6 As shown, it can be seen from the figure that the detection performance of some targets is reduced, the Ct value is delayed, and the fluorescence increment decreases, indicating the specificity and superiority of the composition of the present invention.
[0111] Table 7
[0112]
[0113]
Claims
1. A composition for detecting and typing multiple intestinal pathogens, comprising upstream and downstream primers and probes for detecting at least 4 of the following multiple intestinal pathogens: Upstream and downstream primers and probes for detecting Campylobacter jejuni as shown in SEQ ID NOs: 1 to 3; A probe for detecting Campylobacter coli and upstream and downstream primers as shown in SEQ ID NOs: 4 to 6; Upstream and downstream primers and probes for detecting Vibrio fluvibrios as shown in SEQ ID NOs: 7 to 9; Upstream and downstream primers and probes for detecting Aeromonas hydrophila as shown in SEQ ID NOs: 10 to 12; or The upstream and downstream primers and probes for detecting Cronobacter sakazakii are shown in SEQ ID NOs: 13 to 15.
2. The composition according to claim 1, characterized in that The composition comprises: Upstream and downstream primers and probes for detecting Campylobacter jejuni as shown in SEQ ID NOs: 1 to 3; A probe for detecting Campylobacter coli and upstream and downstream primers as shown in SEQ ID NOs: 4 to 6; Upstream and downstream primers and probes for detecting Vibrio fluvibrios as shown in SEQ ID NOs: 7 to 9; Upstream and downstream primers and probes for detecting Aeromonas hydrophila as shown in SEQ ID NOs: 10 to 12; and The upstream and downstream primers and probes for detecting Cronobacter sakazakii are shown in SEQ ID NOs: 13 to 15.
3. The composition according to claim 2, characterized in that The fluorescent groups of the probes in the combination are different from each other and do not interfere with each other.
4. The composition according to claim 3, characterized in that The fluorescent reporter group of the Campylobacter jejuni probe is FAM; the fluorescent reporter group of the Campylobacter coli probe is HEX; the fluorescent reporter group of the Vibrio fluvial probe is ROX; the fluorescent reporter group of the Aeromonas hydrophila probe is CY5; and the fluorescent reporter group of the Cronobacter sakazakii probe is Quasar 705.
5. The composition according to claim 4, characterized in that The 3' end of the probe also has a quencher group.
6. The composition according to any one of claims 1 to 5, characterized in that The components of the composition are present in admixture.
7. Use of the composition according to any one of claims 1 to 6 in preparing a kit for detecting and typing multiple intestinal pathogens, wherein: The types of the multiple intestinal pathogens are at least four of Campylobacter jejuni, Campylobacter coli, Vibrio fluvialis, Aeromonas hydrophila, and Cronobacter sakazakii.
8. A kit for detecting and typing multiple intestinal pathogens, comprising the composition according to any one of claims 1 to 6.
9. The kit according to claim 8, characterized in that The kit also includes at least one of a nucleic acid releasing reagent, a nucleic acid extracting reagent, and a nucleic acid amplifying reagent.
10. Use of a composition for preparing a composition for detecting and typing a plurality of intestinal pathogens, the detection comprising the following steps: 1) Extracting nucleic acid from the sample to be tested; 2) performing fluorescent quantitative PCR analysis on the nucleic acid obtained in step 1) using the composition according to any one of claims 1 to 6 or the kit according to claim 8 or 9; 3) Obtain and analyze the results.
